Prostaglandin Receptor
Prostaglandin receptors are a group of g-protein coupled receptor that exhibited a variety of functions in regulation of blood pressure and renal function; smooth muscle contraction; inhibition of plate aggregation; immune response etc.
Products Related to Prostaglandin Receptor(174)
- GC15622Dinoprost (Prostaglandin F2a) tromethamine saltCAS: 38562-01-5Purity: >98.00%
Prostaglandin F2α (Prostaglandin F2α tromethamine salt) is an orally active, potent prostaglandin F (PGF) receptor (FP receptor) agonist.
- GC15662ONO-AE3-208CAS: 402473-54-5Purity: >98.00%
ONO-AE3-208 is a prostaglandin receptor (EP) 4-specific antagonist with K i values of 1.3nM, 30nM, 790nM, and 2400nM for EP4, EP3, PGF, and thromboxane receptors, respectively.
- GC15948Prostaglandin E2CAS: 363-24-6Purity: >98.00%
Prostaglandin E2 is a major metabolite produced from arachidonic acid catalyzed by Cyclooxygenase (COX).
- GC16566AL 8810 isopropyl esterCAS: 208114-93-6Purity: >98%
lipid soluble, esterified prodrug form of AL 8810, a FP receptor antagonist
- GC16838(±)-Cloprostenol sodium saltCAS: 55028-72-3Purity: >98.50%
prostaglandin F2α (PGF2α) analog,FP receptor agonist
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC14173 | L-161,982 | 147776-06-5 | >95.00% | |
EP4 receptor antagonist | ||||
| GC14212 | BW 245C | 72814-32-5 | >98.00% | |
DP1 receptor agonist | ||||
| GC14758 | BM 567 | 284464-77-3 | >98% | |
dual acting antithrombogenic agent, acting as an inhibitor of thromboxane A2 (TXA2) synthase and as an antagonist of the TP receptor | ||||
| GC14812 | GW 627368 | 439288-66-1 | >99.50% | |
prostanoid EP4 receptor antagonist | ||||
| GC14859 | BW 246C | 65705-83-1 | >98% | |
DP receptor agonist | ||||
| GC14879 | AH 6809 | 33458-93-4 | >99.00% | |
An EP and DP receptor antagonist | ||||
| GC15157 | SC 51322 | 146032-79-3 | >98.00% | |
EP1 prostanoid receptor antagonist | ||||
| GC15213 | SQ 29,548 | 98672-91-4 | >98.00% | |
TP receptor antagonist | ||||
| GC15622 | Dinoprost (Prostaglandin F2a) tromethamine salt | 38562-01-5 | >98.00% | |
Prostaglandin F2α (Prostaglandin F2α tromethamine salt) is an orally active, potent prostaglandin F (PGF) receptor (FP receptor) agonist. | ||||
| GC15640 | BAY u3405 | 116649-85-5 | >99.00% | |
BAY u3405 is a selective thromboxane A2 (TxA2, IC50=14 nM) antagonist, which also antagonizes CRTH2 (IC50=113 nM) by inhibiting PGD2 binding. | ||||
| GC15662 | ONO-AE3-208 | 402473-54-5 | >98.00% | |
ONO-AE3-208 is a prostaglandin receptor (EP) 4-specific antagonist with K i values of 1.3nM, 30nM, 790nM, and 2400nM for EP4, EP3, PGF, and thromboxane receptors, respectively. | ||||
| GC15911 | Iloprost | 78919-13-8 | >98.00% | |
Iloprost is a prostacyclin (PGI2) analog that affects platelet aggregation. | ||||
| GC15948 | Prostaglandin E2 | 363-24-6 | >98.00% | |
Prostaglandin E2 is a major metabolite produced from arachidonic acid catalyzed by Cyclooxygenase (COX). | ||||
| GC16027 | ONO-8711 | 216158-34-8 | >98.00% | |
EP1 receptor antagonist | ||||
| GC16170 | Ethamsylate | 2624-44-4 | >98.00% | |
Haemostatic drug | ||||
| GC16477 | MK-2894 | 1006036-87-8 | >98.00% | |
| GC16539 | Butaprost | 69685-22-9 | >98.00% | |
A selective agonist for the EP 2 receptors | ||||
| GC16566 | AL 8810 isopropyl ester | 208114-93-6 | >98% | |
lipid soluble, esterified prodrug form of AL 8810, a FP receptor antagonist | ||||
| GC16639 | NS 304 | 475086-01-2 | >99.50% | |
NS 304 (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor). | ||||
| GC16800 | MF498 | 915191-42-3 | >98.50% | |
EP4 receptor antagonist | ||||
| GC16838 | (±)-Cloprostenol sodium salt | 55028-72-3 | >98.50% | |
prostaglandin F2α (PGF2α) analog,FP receptor agonist | ||||
| GC16895 | AL 8810 | 246246-19-5 | >98% | |
Antagonist of prostaglandin F2α (FP) receptor. | ||||
| GC17000 | Nedocromil | 69049-73-6 | >98.50% | |
anti-inflammatory agent | ||||
| GC17224 | AH 23848 (calcium salt) | 81496-19-7 | >98% | |
dual antagonist of TP1 and EP4 receptors | ||||
